Delivery Order SPE2DB20D7066-SPE2DB25FC2FY
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $22,935.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Losartan-HCTZ 100-12.5 mg tablets to support military healthcare programs. The order has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.09, is for the delivery of Losartan-HCTZ 100-25 mg tablets in quantities of 1,000. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan-HCTZ 100-25 mg tablets in quantities of 1,000. The $2,670.68 firm fixed price contract was awarded on June 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 24, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $40,008.09, is for the supply of Losartan-HCTZ 100-25 mg tablets in 1,000-count bottles. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,362.10 Firm Fixed Price Delivery Order contract is for the supply of Losartan-HCTZ 100-25 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,436.44 firm fixed-price delivery order contract (SPE2DX15D3015|SPE2DX24F0EN0) to AmerisourceBergen Drug Corp for the supply of 4,563,434,205 units of Losartan-HCTZ 50-12.5 mg tablets. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The $20,986.67 firm fixed price contract has a completion date of September 16, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.04 firm fixed-price delivery order is for the supply of Losartan-HCTZ 50-12.5mg tablets in 1,000-count packages. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,551.18 firm fixed-price delivery order is for the supply of 90-count bottles of the medication Losartan-HCTZ 100-25 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,547.58, is for the delivery of Losartan-HCTZ 100-25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at up to $999,999,999.00, serves as the...